EMD-66849

Helical reconstruction
2.86 Å
EMD-66849 Deposition: 30/10/2025
Map released: 04/11/2026
Last modified: 04/11/2026
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-66849

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-9xgj summary report (pdf.gz) Map-9xgj FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

Second-generation 2N4R human tau filaments seeded by Alzheimer's disease tau in the presence of heparan sulfate

EMD-66849

Helical reconstruction
2.86 Å
EMD-66849 Deposition: 30/10/2025
Map released: 04/11/2026
Last modified: 04/11/2026
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Homo sapiens
Sample: Tau
Fitted models: 9xgj

Deposition Authors: Zeng W, Sun S, Shi Y, He Z

Golgi-derived glycosaminoglycans are involved in pathological tau seeds formation as the cofactor in Alzheimer's disease and related tauopathies